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Changes in the in utero environment result in generational transfer of maladapted physiology in the context of conditions such as
stress, obesity, and anxiety. Given the signiﬁcant contribution of noncommunicable diseases—which are characterised by chronic
inﬂammation—to population mortality, the potential for chronic maternal inﬂammation mediating foetal programming is a
growing concern. The extent of generational transfer in terms of immune functionality and leukocyte glucocorticoid sensitivity
was investigated over two generations of oﬀspring (F1 and F2) in a model of chronic LPS-induced maternal inﬂammation in
C57/BL/6 mice. Maternal inﬂammation resulted in glucocorticoid hypersensitivity (increased glucocorticoid receptor expression
levels) in the majority of leukocyte subpopulations in both F1 and F2 oﬀspring. Furthermore, splenocytes stimulated with LPS
in vitro exhibited exacerbated inﬂammatory cytokine responses, which were even more prominent in F2 than F1; this eﬀect
could be ascribed to NLRP3 inﬂammasome hyperactivity in F1 but not F2. Current data illustrates that parental chronic
inﬂammation may mediate the inﬂammatory proﬁle in oﬀspring, potentially propagating a maladapted proinﬂammatory
phenotype in subsequent generations.
1. Introduction
The high mortality resulting from noncommunicable
diseases—currently accounting for over 70% of global death
rates, with cardiovascular disease, cancers, diabetes, and chronic
pulmonary diseases taking the forefront [1, 2]—increases the
potential risk for generational transfer of maladapted physi-
ology. This is a signiﬁcant concern of modern societies, with
published literature showing a precedent for transgenera-
tional inheritance in oﬀspring; the impact of maternal stress
exposure, whether acute or chronic, is reportedly passed on
to her oﬀspring and, to an extent, her grand oﬀspring [3–5].
The plasticity of foetal development is notoriously sensi-
tive to environmental ﬂuctuations, which is mediated by a
variety of stressors. The foetal programming hypothesis
suggests that adaptations occurring during the critical
embryonic and foetal developmental stages determine the
established point of physiological and metabolic responses
and susceptibility to disease in later life [6]. This dysfunction
is evident in transgenerational studies involving obesity
[7–10], social stressors [11, 12], anxiety [13], and LPS expo-
sure [7, 14, 15], which is, at least in part, due to changes in
the in utero microenvironment.
The in utero milieu is subject to a variety of endocrine
and immune adaptations, which is induced to sustain a
favourable microenvironment for growth and maturation at
the maternal-foetal interface. In terms of immunity, the
primary alteration is the predominant type II helper
T-lymphocyte (TH2) bias that exists during pregnancy to
facilitate maternal tolerance at the maternal-foetal interface
[16]. The increased progesterone, estradiol, and prostaglan-
din D2 (PGD2) levels during gestation seem to further
encourage this TH2 proﬁle, thus maintaining a relatively
more immunosuppressive state in mothers [17, 18]. Maternal
inﬂammation during gestation seems to disrupt this TH2 bal-
ance, resulting in a more proinﬂammatory TH1 phenotype,
which adversely aﬀects oﬀspring. Both maternal pre- and
perinatal inﬂammations are known to be causal in preterm
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birth and foetal loss [18–20]. Furthermore, it has far
reaching eﬀects on oﬀspring behaviour [21, 22], metabolic
function [7, 23], and immune functionality [7, 15, 23, 24].
Glucocorticoid and hypothalamic-pituitary-adrenal (HPA)
homeostasis [22, 24, 25] is also aﬀected by gestational
inﬂammation. The impact of maternal stress on the foetal
HPA axis in the perinatal state has been comprehensively
reviewed in by Weinstock [20], who concluded that gesta-
tional stress and higher levels of maternal and foetal
plasma corticosterone can result in the downregulation of
foetal glucocorticoid receptors, impairing the feedback
loop of the HPA axis into adulthood. Emerging evidence
is suggesting that this maladaptive endocrine state may
also be linked to sustained maladapted immunological
functionality. For example, in rodents, stressed generation
zero (F0) dams displayed higher circulating proinﬂamma-
tory cytokine concentrations [15], higher leukocyte counts
[7], and increased circulating cortisol levels [26]. This dys-
regulation was reported to persist to the F1 and F2 gener-
ations of stressed groups [12, 27, 28].
Based on previous literature in transgenerational rodent
models of social stress, as well as human models of posttrau-
matic stress disorder (PTSD) and trauma [29–32], chronic
HPA axis activation promotes glucocorticoid insensitivity,
resulting in a proinﬂammatory phenotype, predisposing
subsequent generations to increased risk of morbidity from
noncommunicable disease in adulthood. Although the eﬀects
of psychological stressors during the gestational period on
the maladaptation of the HPA axis have been comprehen-
sively reported on, little data is available on the eﬀects of
chronic stressors on functional capacity of the immune
response in F1 and F2 generations or their glucocorticoid
sensitivity in response to chronic maternal inﬂammation.
Thus, the purpose of our study was to delineate the plasticity
of generational transfer in immune functionality and leu-
kocyte glucocorticoid sensitivity, in a model of chronic
LPS-induced maternal inﬂammation. Furthermore, the role
of the NLRP3 inﬂammasome was investigated in this context.
2. Materials and Methods
2.1. Animal Experiments. Ethical clearance was obtained
from the Stellenbosch University Animal Research Ethics
Committee (SU-ACUM14-00004). C57/BL/6 mice were
housed under temperature-controlled conditions under a
12-hour dark-light cycle, with ad libitum access to standard
rodent chow. After one-week acclimatization, 6-week-old
dams (generation F0) were naturally mated with age-
matched males. The breeding and propagation of the mice
is illustrated in Figure 1. Females were placed with males
overnight and removed the following morning. Successful
mating was conﬁrmed by the presence of a vaginal plug.
The plug-positive dams were moved to separate cages and
randomised to receive either LPS (from Escherichia coli;
Sigma, USA; serotype 0127: B8) at 10 μg/kg bodyweight,
prepared in 0.9% saline solution, or 0.9% saline solution
(control) at a ﬁnal volume of 50 μl.
The LPS or saline treatment was administered via intra-
peritoneal injection and repeated every seven days for the
duration of gestation. The dose was based on the body mass
prior to the ﬁrst injection (200 ng LPS per 20 g body weight)
and was kept constant throughout the duration of the gesta-
tion. A total of 3 injections were administered to each dam
over the duration of gestation, which was either 19 or 20 days
Saline LPS
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Treated
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Figure 1: Breeding schematic for (a) saline and (b) LPS-exposed groups. The n represents the number of mice for each subsequent generation
and gender group.
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for all animals. For the duration of the intervention protocol,
females were monitored daily for any signs of morbidity,
such as lethargy, weight loss, or vaginal bleeding—none was
observed. F0 was terminated 4 weeks after weaning of oﬀ-
spring (i.e., at 14 weeks of age and 5 weeks after the last
LPS injection).
The ﬁrst generation of oﬀspring (F1), resulting from the
F0 mating, was weaned at 3 weeks of age. Oﬀspring siblings
were grouped together, but sexes were separated into two
cages until 8 weeks of age; after which, 4 males and 4 females
per treatment group were terminated for further experimen-
tal analysis. The remaining animals were bred with wild-type
animals for the second generation of oﬀspring (F2).
For F2 generation, the F1 mice were mated with wild-
type C57/BL/6 mice and the same procedure was followed
for weaning but with no further intervention. Data on breed-
ing, oﬀspring litter size, and gestational duration did not
seem to be diﬀerent across generations or as result of LPS
exposure (Supplementary Material I). As for F1, F2 mice
were killed by cervical dislocation at 8 weeks of age.
2.2. Sample Collection. Whole blood was collected by cardiac
puncture and transferred to K2EDTA microtubes. An aliquot
was assigned for full blood and diﬀerential leukocyte counts
on the CELL-DYN 3700CS haemocytometer (Abbott Diag-
nostics), while the remaining blood sample was used to col-
lect plasma for assessment of corticosterone concentrations.
Corticosterone concentrations were determined by quan-
titative ELISA (Demeditec Corticosterone rat/mouse ELISA,
Demeditec Diagnostics, Germany), as per manufacturer’s
instructions. The concentrations were calculated in Micro-
soft Excel using a 6-point standard curve with a logistic
regression algorithm. The detection range of the kit was
6.1-2250 ng/ml. The kit has an intra-assay variation of 8.9%
and interassay variation of 7.2%.
Mouse spleens were dissected under sterile conditions
and collected into ice-cold complete RPMI 1640 medium
(supplemented with 10% foetal bovine serum, 1% penicil-
lin-streptomycin, and 1% gentamicin). Both LPS-treated
dams and LPS-aﬀected oﬀspring displayed macroscopically
visible larger spleen sizes in comparison to saline-treated
dams or saline-aﬀected oﬀspring, respectively. Exact organ
mass was however not determined due to the requirement
for sterility in culturing splenocytes.
2.3. Cell Preparation.A single-cell suspension of murine sple-
nocytes was generated by mechanical dissociation, by passing
dissected tissue through a sterile 70 μm cell strainer (BD Bio-
sciences, USA). The cell strainer was rinsed with complete
RPMI 1640 medium to remove any attached cells. Red blood
cells were lysed with 1x ACK lysis buﬀer (150mM NH4Cl,
10mM KHCO3, and 0.1mM NA2EDTA in ddH2O) for 5
minutes at room temperature, and splenocytes were washed
with 1x Dulbecco’s phosphate-buﬀered saline (DPBS, Gibco,
USA). The cells were pelleted at 300×g for 5 minutes at room
temperature, the supernatant was aspirated, and the pellet
was resuspended in complete RPMI 1640. The cells were
counted and adjusted to 1 × 107/ml viable cells and used
immediately for cell counting assays or frozen and stored in
liquid nitrogen for subsequent batch analysis of the inﬂam-
masome and splenocyte functional capacity.
2.4. Basal Leukocyte Glucocorticoid Receptor Assessment. All
reagents were prepared as per manufacturer’s instructions
prior to use. For permeabilisation of samples, the BD
Cytoﬁx/Cytoperm kit was used.
The staining buﬀer was prepared as 1x DPBS with 5%
bovine serum albumin (Invitrogen, USA) and 1% NaN3
and stored at 4°C until use. The antibodies were titrated to
determine optimal dilution for experiments. The antibodies
and dyes and their respective dilutions are as follows:
CD16/32 Fc block (BD Biosciences); Zombie Aqua Fixable
Viability dye (BioLegend); NK1.1 BV421, clone PK136
(BioLegend); TCRβ FITC, clone H57-597 (BD Biosciences);
F4/80 PE-CF594, clone T45-2342 (BD Biosciences); CD11b
PerCP-Cy5.5, clone M1/70 (BD Biosciences); NR3C1
Ax647, clone BugR2 (Novus Biologicals); and Ly6G
APC-Cy7, clone 1A8 (BD Biosciences).
Brieﬂy, 1 × 106 splenocytes were incubated with Zombie
Aqua dye in DPBS for 30 minutes at room temperature. After
incubation, the cells were washed twice with DPBS and the
supernatant was aspirated. The cells were then incubated
with CD16/32 mouse Fc block antibody for 5 minutes in
staining buﬀer, where after a master mix of the appropriate
cell surface marker, antibodies are added. The cells were
mixed thoroughly and incubated for 30 minutes at 4°C. The
cells were then washed twice with staining buﬀer and per-
meabilised for 20 minutes at 4°C. After incubation, the cells
were washed in 1x perm buﬀer and pelleted at 600×g for 5
minutes. Splenocytes were then resuspended with the appro-
priate dilution of the intracellular NR3C1 antibody. The
samples were incubated at 4°C for 30 minutes in the dark.
After incubation, the cells were washed twice with 1x perm
buﬀer and, as a last step, resuspended in 300 μl staining buﬀer
after centrifugation. The sampleswere stored at 4°C for amax-
imum of 6 hours before acquisition using a ﬂow cytometer.
2.5. Assessment of Inﬂammasome Activation. Splenocytes
were thawed at 37°C and washed twice (300×g, 5 minutes)
with prewarmed complete RPMI 1640 media. Cells were
seeded at a density 2 × 106/ml in 10 cm bacteriological plates
in 20ml complete RPMI 1640 media supplemented with 10%
L929 media and incubated at 37°C at 5% CO2. On day 3, the
plate was washed with prewarmed DPBS, to remove unat-
tached cells, and the media was replaced. On day 6, the cells
were harvested using 5ml Accutase and resuspended at a
concentration of 2 × 105 cells per well in poly-HEMA-
coated 48-well plates in 490 μl RPMI 1640.
Splenocytes were incubated in RPMI 1640 medium with
either LPS (100 ng/ml) (two wells per sample) or RPMI
1640 only (one well per sample) for 6 hours at 37°C. For each
sample, nigericin (10 μM, Sigma-Aldrich, USA) was added to
one LPS well for the last 30 minutes of incubation. Following
incubation, the cells were transferred into 1.5ml microcentri-
fuge tubes and centrifuged at 300×g for 5 minutes to pellet
cells; after which, they were ﬁxed with 4% paraformaldehyde.
Antibodies used for labelling were titrated to determine
optimal dilution for experiments. The antibodies and dyes
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and their respective dilutions used for the study are as fol-
lows: mouse Fc block (BD Biosciences); CD11b BV421, clone
M1/70 (BD Biosciences); F4/80 PE, clone T45-2342 (BD Bio-
sciences); pro-IL-1β PE-Cy7, clone NJTEN3 (eBiosciences);
and ASC/TMS1 Ax647 (Novus Biologicals).
The cells were permeabilised with BD CytoFix/Cytoperm
buﬀer for 20 minutes at 4°C and subsequently washed twice.
Prior to staining, CD16/32 mouse Fc block was added to the
samples for 5 minutes at 4°C to block nonspeciﬁc binding.
Thereafter, a master mix of the appropriate antibodies for
intracellular and extracellular markers was added and the
samples were incubated for 30 minutes at 4°C in the dark.
After incubation, the cells were resuspended in 1x BD perm
buﬀer and centrifuged at 600×g for 5 minutes, at room tem-
perature. After washing, the supernatant was discarded and
the cells were resuspended in staining buﬀer before acquisi-
tion on the ﬂow cytometer.
2.6. Flow Cytometric Acquisition and Analysis. Acquisition
was performed on the BD FACSAria IIu ﬂow cytometer
(BD Biosciences), with BD FACSDiva™ version 8.1 software
for data acquisition and analysis. Application settings in the
BD FACSDiva software were used to standardize experimen-
tal data. As an experimental control, lot-speciﬁc 8-peak bead
control was included as daily standardization validation to
ensure that all settings were valid and reproducible on any
ﬂow cytometer employed for this purpose. All data ﬁles were
exported as FCS 3.1 ﬁles and further analysed in FlowJo™
v10.4.2.
The samples were resuspended by vortexing for 5
seconds prior to data acquisition. For the assessment of the
glucocorticoid receptor expression level on speciﬁc leukocyte
subpopulations, a minimum of 200 000 and a maximum of
500 000 live, gated, and singlet events were collected for each
sample. The gating strategies are deﬁned in Figure 2. Spleno-
cytes were identiﬁed using FSC vs. SSC; thereafter, dead cells
were excluded. Doublet discrimination was performed by
applying a gate around the linear population in the SSC-H
vs. SSC-A plot. Cells of interest were then identiﬁed from
the single-cell population as follows: T-lymphocytes (TCRβ+
NK1.1-), NKT lymphocytes (TCRβ+ NK1.1+) NK cells
(TCRβ- CD11b+ NK1.1+), neutrophils (TCRβ- CD11b+
Ly6G+), monocytes (TCRβ- CD11b+ F4/80-), and macro-
phages (TCRβ- CD11b+ F4/80+). Relative glucocorticoid
receptor (NR3C1) expression for each cell population was
quantiﬁed as relative median ﬂuorescence intensity (MFI).
Bulk gating was used to apply these gate coordinates to each
generation, and all the gates were inspected and adjusted
manually for each sample, if needed. All data for the experi-
mental design was exported to Microsoft Excel.
For the inﬂammasome assay, a minimum of 5000
CD11b+F4/80+ macrophages were collected per sample.
All samples were run on application settings, and compen-
sation was performed every run. The gating strategies are
deﬁned in Figure 2. Macrophages were gated on the FSC
vs. SSC dot plot, and doublets were excluded using FSC-H
vs. FSC-A. Macrophages were further identiﬁed by CD11b
+F4/80+ expression, and within this population, pro-IL-1β
expression was quantiﬁed as relative median ﬂuorescent
intensity (MFI). Inﬂammasome adaptor protein Apoptosis-
Associated Speck-Like Protein Containing CARD (ASC)
speck formation was assessed by plotting ASC-A vs. ASC-H.
The ASC speck-containing cells were gated for quantiﬁcation
in the doublet gate as deﬁned by accepted methodology [33].
As a brief introduction, the inﬂammasome complex is amulti-
protein protein structure, responsible for the tightly con-
trolled secretion of both IL-1β and IL-18 that recognises
pathogens via Toll-like receptor binding in combination with
NOD-like receptor binding. Inﬂammasome assembly, and
thereby the release of biologically active IL-1β, is a two-step
process: ﬁrstly, by the production of inactive pro-IL-1β, stim-
ulated by TLR ligand binding, and secondly, the formation of
the inﬂammasome complex (ASC formation) which cleaves
inactive pro-IL-1β into active IL-1β (Jha, Brickey, Pan, &
Ting, 2017; Strowig, Henao-Mejia, Elinav, & Flavell, 2012).
The NLRP3 is the best-studied inﬂammasome complex
and has been implicated in obesity, heart disease, neuroin-
ﬂammation, and other systemic inﬂammatory dysregulation
(Jha et al., 2017; Menu, Vince, Vince, & Menu, 2011; Strowig
et al., 2012).
2.7. Splenocyte Ex Vivo Functional Capacity. Functional
capacity of splenocytes, in terms of their basal and
LPS-induced cytokine secretion proﬁle, was determined for
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Figure 2: Representative images illustrating the gating strategy for basal glucocorticoid receptor expression on splenocytes (a) and assessment
of inﬂammasome function (b).
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samples from all three generations of mice. Isolated spleno-
cytes were resuspended in RPMI 1640 at a cell concentration
of 1 × 106 cell/ml and plated in 24-well plates at 1ml per
well. The splenocytes were treated with either LPS (from
Escherichia coli; Sigma, USA; serotype 0127: B8) at 1 μg/ml
in RPMI 1640 (LPS-induced/stimulated) or complete RPMI
1640 only (basal/unstimulated) and incubated for 18 hours
at 37°C, 5% CO2. After stimulation, culture supernatants
were collected and stored at -80°C for batch analysis.
The MAP Mouse Cytokine/Chemokine Magnetic Bead
panel kit (Millipore, USA) was employed to assess the
cytokine proﬁle (IL-1β, IL-6, IL-10, TNF-α, and IFN-γ) in
stimulated and unstimulated supernatant samples, using
the Bio-Plex 200 system (Bio-Rad, USA) equipped with the
Bio-Plex Manager™ software. Cytokine concentrations were
automatically calculated based on a 6-point standard curve
(in duplicate) ﬁtted with a ﬁve-parameter logistic regression
algorithm. The lowest limit for the detection of IL-1β, IL-6,
TNF-α, IL-10, and IFN-γ was 1.1 pg/ml, 2.3 pg/ml, 2.0 pg/ml,
and 1.1 pg/ml, respectively. The highest limit of detection was
10 000 pg/ml for all cytokine kits used.
2.8. Data Reduction and Statistical Analysis. For ﬂow cyto-
metric data, percentage of cells for each leukocyte population
identiﬁed and median ﬂuorescent intensity (MFI) were used
in statistical analyses. All data was exported to Microsoft
Excel from respective analysis programs and consolidated.
Data was analysed in Statistica version 13.2 (StatSoft
Software, USA), and graphs were generated in GraphPad
Prism 7.04 (GraphPad Software Incorporated, USA). After
conﬁrming normalcy of data distribution, one-way analysis
of variance (ANOVA) was performed for the F0 LPS and
saline comparison and a two-way analysis of variance
(ANOVA) was employed for the F1 and F2 comparison.
Fisher’s LSD post hoc tests were employed to analyse the
statistical signiﬁcance of diﬀerences between control and
LPS-aﬀected groups within the same generation. Data is
presented as means and standard errors of the mean (SEM),
and p < 0 05 or less was regarded as signiﬁcant.
3. Results
3.1. Gestational Chronic LPS-Induced Inﬂammation Aﬀects
Maternal Physiology Even after the Recovery Period. After 3
weeks of recovery, plasma corticosterone levels were similar
between control and LPS-exposed groups. Insuﬃcient num-
bers per group exclude ﬁrm conclusions on this, but individ-
ual data (Supplementary Material II) seems to suggest that at
this time point, the majority—but not all—mothers have
fully recovered in terms of circulating glucocorticoid levels.
As mentioned above, spleen size for LPS-treated dams
and their oﬀspring was visibly increased, in line with reports
in other models of inﬂammation [34, 35]. Blood and spleno-
cyte absolute counts and relative distributions are summa-
rized in Table 1. In line with the glucocorticoid (GC) data,
in circulation, neither total nor diﬀerential leukocyte counts
diﬀered between groups. When considering splenocyte
counts, the same representation is seen, with the exception
of splenic eosinophil counts, which were signiﬁcantly higher
(p < 0 05) in the LPS-exposed group. It is possible that acti-
vated neutrophils were counted as eosinophils by the auto-
mated cell counter. Since it was not logistically possible to
exclude this possibility through manual assessment of blood
smears, this result was excluded from interpretation. (Given
the relatively low eosinophil counts, it is unlikely that neutro-
phil counts would have been signiﬁcantly aﬀected.)
When analysing relative distribution of splenocytes using
a ﬂow cytometer (Figure 3), again, most cell types appeared
to have returned to control levels, except for NKT-lympho-
cytes, which remained relatively lower in the LPS-exposed
group even after 5 weeks of recovery.
Relative basal GR expression in response to repeated LPS
exposure in F0 mice diﬀered between diﬀerent types of sple-
nocytes at a time point 3 weeks after the last LPS challenge
(Figure 4). Previous LPS exposure resulted in maintained
relatively higher GR expression on T-lymphocytes, NK
cells, and monocytes but lower GR expression on macro-
phages and seemingly no lasting eﬀect on neutrophils and
NKT-lymphocytes.
Both basal and LPS-induced capacities of splenocytes to
secrete proinﬂammatory cytokines were not signiﬁcantly
aﬀected by previous repeated LPS exposure (Supplementary
Material III). However, a general pattern seems to exist for
both pro- and anti-inﬂammatory cytokine levels, which were
on average slightly higher in previously LPS-exposed groups.
This of course remains to be substantiated in a larger group
of animals.
3.2. Transgenerational Inheritance of Chronic LPS Exposure.
Plasma corticosterone levels for the F1 and F2 generations
showed no signiﬁcant response to the F0 maternal interven-
tion, when comparing LPS groups to their respective
Table 1: Peripheral blood and splenic diﬀerential leukocyte counts
in the F0 control and F0 LPS-exposed groups. One-way ANOVA
was used to compare F0 LPS and F0 saline groups. Data is
represented as means ± SD.
Compartment
F0 control
(1 × 109 cells/L)
F0 LPS
(1 × 109 cells/L)
Total
leukocytes
Circulation 2 82 ± 0 41 3 15 ± 0 70
Spleen 3 80 ± 0 54 4 04 ± 0 55
Lymphocytes
Circulation 1 29 ± 0 48 1 37 ± 0 33
Spleen 3 11 ± 0 48 3 24 ± 0 69
Monocytes
Circulation 0 147 ± 0 061 0 094 ± 0 048
Spleen 0 231 ± 0 037 0 279 ± 0 074
Neutrophils
Circulation 1 21 ± 0 78 1 57 ± 1 05
Spleen 0 127 ± 0 041 0 256 ± 0 129
Eosinophils
Circulation 0 024 ± 0 013 0 020 ± 0 007
Spleen 0 016 ± 0 004a 0 032 ± 0 016b
Basophils
Circulation 0 152 ± 0 092 0 090 ± 0 059
Spleen 0 319 ± 0 063 0 382 ± 0 115
LPS: lipopolysaccharide. Results are depicted as mean ± SEM. F0 control,
n = 5; F0 LPS, n = 6. Signiﬁcance: abp < 0 05.
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generational controls, albeit somewhat inconclusive due to
limited sample size (Supplementary Material II).
In terms of leukocyte counts (Figure 5), total and diﬀer-
ential leukocyte count was unaﬀected in circulation
(Figure 5, A–F). In contrast, total count was signiﬁcantly
increased in spleens of generation 1 LPS-aﬀected (F1LPS)
mice but signiﬁcantly decreased in F2 LPS-aﬀected (F2LPS)
animals (Figure 5, G–L). Total lymphocyte counts showed
signiﬁcantly higher in association with inherited LPS expo-
sure in both generations. Interestingly, counts for both
neutrophils and basophils—the early phase proinﬂammatory
role players—were signiﬁcantly lower in spleens of LPS-
aﬀected animals, an eﬀect that was even more pronounced
in F2 than F1. A similar eﬀect was also seen for splenic mono-
cytes, with statistical signiﬁcance only reached in F2.
The relative frequencies of speciﬁc splenocytes mirrored
absolute count data, also showing lower relative counts for
neutrophils and monocytes in response to ancestral LPS
exposure (basophils were not assessed) (Figure 6). Although
relative counts for macrophages again reﬂect a decrease in
association with LPS for F2, the opposite is seen in F1—this
may indicate a phenotype switch to favour F4/80+ macro-
phages. In addition, this analysis revealed that the increased
splenic lymphocyte count can be ascribed to T-lymphocytes
rather than NKT-lymphocytes or NK cells, which appeared
unaﬀected by the LPS intervention.
Turning attention to GR expression levels in oﬀspring,
the majority of leukocyte types exhibited increased GR
expression levels in response to the LPS intervention
(Figure 7). Of interest, two exceptions were evident—for F1,
both neutrophil GR and macrophage GR seemed unaﬀected.
However, when considering F0, F1, and F2 responses to LPS
together, this generation seems to reﬂect a transitional phase
to eﬀects only statistically and signiﬁcantly evident in F2.
In terms of functional capacity, basal cytokine secretion
was not aﬀected by ancestral LPS exposure in either F1
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Figure 3: Frequency distribution of splenocyte populations between control and LPS-exposed female mice (F0), 3 weeks after the ﬁnal LPS
challenge: (a) T-lymphocytes, (b) NKT-lymphocytes, (c) NK cells, (d) neutrophils, (e), monocytes, and (f) macrophages. One-way ANOVA
was used to compare F0 LPS and F0 saline groups. Data is representedmean ± SEM. F0 control, n = 5; F0 LPS, n = 6. Signiﬁcance is depicted as
follows: ∗∗∗p
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or F2, with levels mostly below kit detection thresholds
(Supplementary Material III).
However, in response to in vitro LPS challenge, the non-
signiﬁcant increase in cytokine production seen in mothers
even after a period of recovery (Supplementary Material
III), which suggests a transient cytokine response to the
LPS stimuli, was propagated and seemed to become more
signiﬁcant with each subsequent generation for the majority
of cytokines assessed (Figure 8).
3.3. Contribution of NLRP3 Inﬂammasome. In the current
study, mouse splenocytes were frozen for an extended period
of time (approximately 6 months) to facilitate batch analysis
of all generations. In these previously frozen cells, the
addition of nigericin proved to be unnecessary to facilitate
conversion to IL-1β. Thus, only basal and LPS-induced
inﬂammasome activation is presented (Figure 9). The control
F0 splenic F4/80+ macrophages exhibited the expected LPS-
induced increase in pro-IL-1β production, as well as conver-
sion to IL-1β (as indicated by ASC complex formation). In
the LPS-exposed group, basal intracellular pro-IL-1β levels
were signiﬁcantly higher (p < 0 05) when compared to con-
trols. However, relatively less eﬃcient conversion occurred
in response to acute LPS challenge. In generation F1, cells
seem to maintain constant pro-IL-1β expression levels but,
in utero LPS exposure, was associated with more eﬃcient
conversion to IL-1β both basally and in response to acute
LPS challenge. In F2, no signiﬁcant diﬀerences are evident
between control and LPS-exposed oﬀspring.
4. Discussion
The current study has successfully established an in vivo
mouse model of chronic maternal inﬂammation, by expan-
sion of the maternal periconception systemic inﬂammation
(MPSI) protocol established by Williams et al. [15]. For the
current model, the low-dose (10 μg/kg, every 7 days) LPS
intraperitoneal administration in pregnant dams was contin-
ued until the end of the gestation period. Signiﬁcant alter-
ations in the immunological and HPA functionality are
reported for all generations.
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Figure 4: Basal cytoplasmic glucocorticoid receptor protein expression levels on splenocyte populations collected from F0 control mice vs.
mice 3 weeks after repeated LPS treatment: (a) T-lymphocytes, (b) NKT-lymphocytes, (c) NK cells, (d) neutrophils, (e) monocytes,
and (f) and macrophages. One-way ANOVA was used to compare F0 LPS and F0 saline groups. Data is represented mean ± SEM.
F0 control, n = 5; F0 LPS, n = 6. Signiﬁcance is depicted as follows: ∗p < 0 05 and ∗∗p < 0 01.
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and ∗∗∗∗p < 0 001.
0
10
20
30
40
T-
ly
m
ph
oc
yt
es
 (%
)
F1 control F2 controlF1 LPS F2 LPS
⁎⁎
(a)
0
1
2
3
4
N
KT
 ly
m
ph
oc
yt
es
 (%
)
F1 control F2 controlF1 LPS F2 LPS
(b)
0
1
2
3
N
K 
ce
lls
 (%
)
F1 control F2 controlF1 LPS F2 LPS
(c)
0
1
2
4
N
eu
tro
ph
ils
 (%
) 3
F1 control F2 controlF1 LPS F2 LPS
(d)
0
1
3
5
M
on
oc
yt
es
 (%
) 4
2
F1 control F2 controlF1 LPS F2 LPS
⁎⁎⁎⁎
(e)
0.0
0.5M
ac
ro
ph
ag
es
 (%
)
1.0
1.5
2.0
F1 control F2 controlF1 LPS F2 LPS
⁎⁎⁎⁎ ⁎
(f)
Figure 6: Frequency of splenocyte populations between LPS-aﬀected and control F1 and F2 generations. (a) T-lymphocytes, (b) NKT-
lymphocytes, (c) NK cells, (d) neutrophils, (e), monocytes, and (f) macrophages. Two-way ANOVA and Fisher’s post hoc tests were
used to compare LPS and saline groups. Data is represented mean ± SEM, n = 8 per group. Signiﬁcance is depicted as follows: ∗p < 0 05;
∗∗p < 0 01; ∗∗∗ < 0 001, and ∗∗∗∗p < 0 001.
8 Mediators of Inﬂammation
Chronic MPSI induced postnatal changes in the HPA
axis, as well as in the leukocyte proﬁle and functional
capacity in mothers; some of which remained evident even
after a recovery period. Furthermore, signiﬁcant lasting
eﬀects of the LPS-aﬀected in utero microenvironment are
evident in the F1 and F2 generations, with regard to both
circulating and reservoir immune cells, as well as glucocor-
ticoid responsiveness and cytokine responses to ex vivo
LPS challenge.
The current data contributes to the knowledge regarding
transgenerational inheritance of physiological adaptations to
gestational chronic inﬂammation. The detailed leukocyte
subpopulation-speciﬁc analyses, in particular, provide new
insight into the role of an altered in utero environment on
the immunological phenotypes of both the F1 and F2 gener-
ations of oﬀspring.
4.1. Maternal Adaptation to Gestational Chronic LPS
Administration. In terms of gestation and litter size, neither
was signiﬁcantly aﬀected by chronic MPSI, although oﬀ-
spring number was lower than that reported after either
single-dose LPS [15] or immobilisation stress during gesta-
tion [36], suggesting that the current model could represent
a comparatively more severe stressor.
An acute single low-dose (10 μg/kg) LPS challenge is
known to induce an inﬂammatory cytokine response in
dams, which return to control levels by 72 hours postadmi-
nistration [15]. Similarly, in a mild model of chronic systemic
administration (6.45 μg/kg LPS per day, administered by
osmotic pump during pregnancy and lactation) [7], LPS-
administered dams displayed no signiﬁcant impact on the
postnatal systemic inﬂammatory proﬁle at one week after
cessation of LPS challenge. However, in the current study,
a relatively more severe LPS challenge (weekly bolus injec-
tion of 10μg/kg) resulted in a long-term reduction in
splenic NKT lymphocyte counts. In addition, in line with
published data on GR expression generated in total leuko-
cytes or total lymphocytes in circulation [37], macrophage
GR was indeed lower in response to the chronic inﬂam-
matory stimulus. However, in contrast, subpopulation-
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Figure 7: Glucocorticoid receptor levels in spleen T-lymphocytes (a), NKT-lymphocytes (b), NK cells (c), neutrophils, (d) monocytes, (e) and
macrophages (f) of F1 and F2-untreated and LPS-treated generations. Two-way ANOVA and Fisher’s post hoc tests were used to compare
LPS and saline groups. Data is represented mean ± SEM, n = 8 per group. Signiﬁcance is depicted as follows: ∗∗p < 0 01; ∗∗∗p < 0 001, and
∗∗∗∗p < 0 001.
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speciﬁc analysis indicated an increased GR expression on
T-lymphocytes, NK cells, and monocytes—minority cell
types which may not necessarily reﬂect in total T or total
leukocyte GR analyses—suggesting a more diﬀerential
leukocyte response to this particular chronic stress than
previously thought.
The gestational LPS challenge indicated more signiﬁcant
eﬀects on NKT cell numbers in the spleen, which is in line
with and expand on available relevant literature. The low
splenic NKT-lymphocyte frequencies reported here are likely
due to NKT cell migration from the spleen into the maternal
decidua [38, 39]. Alternatively, a decreased availability of
NKT cells for storage in the spleen may result from increased
recruitment of NKT cells from circulation into the maternal
decidua. Previously, LPS exposure and risk of foetal loss were
attributed to the increased presence of invariant NKT lym-
phocytes (iNKTs) in the maternal decidua [40]. iNKTs con-
tribute to the majority of NKT numbers and typically
coexpress T-lymphocyte receptors as well as NK cell recep-
tors. iNKTs are signiﬁcantly implicated in LPS-induced preg-
nancy loss [41] and preterm delivery [19, 39, 41] through
inﬂammatory cell activation as well as TH-1 and TH-17
responses. This interpretation is in line with ﬁndings in a
pilot study to the current study, where the initiation of
LPS-induced inﬂammation prior to conception prevented
pregnancy in the majority of dams (data not shown). Fur-
thermore, the NKT adaptation in the current study was sus-
tained for several weeks after the end of the administration of
the LPS stimulus, suggesting an inability of pregnant dams to
readily recover, which may have predisposed their oﬀspring
to related (mal)adaptations.
Assessment of GR expression levels in a leukocyte
subpopulation-speciﬁc manner provided more informa-
tion. Clinical evidence has substantiated the hypothesis
that chronic stress directly inﬂuences leukocyte GR expres-
sion and functionality, although some contrasting data has
been reported. For example, in PTSD veterans, lower total
leukocyte GR density was reported [42], speciﬁcally in
T-lymphocytes, B-lymphocytes, and NK cells [43]. In con-
trast, PTSD and anxiety disorders have also been associated
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with elevated lymphocyte GR expression [44], speciﬁcally in
neutrophils [45]. This is possibly the result of glucocorticoid
adaptation occurring across a continuumwhere GR levels ini-
tially increase in response to acutely increased glucocorticoid
levels, followed by GR downregulation when glucocorticoid
hypersecretion becomes chronic. In terms of inﬂammation,
this results ﬁrstly in an anti-inﬂammatory eﬀect, which
changes to a more proinﬂammatory outcome with the onset
of glucocorticoid resistance. In the current study, signiﬁcantly
higher GR expression was evident in T-lymphocytes and NK
cells in response to maternal chronic gestational LPS expo-
sure. The higher GR levels in T-lymphocytes may, at least in
part, be due to the presence of T-regulatory cells, which pro-
mote autoimmune protection during pregnancy [46]. Future
detailed analysis could shed more light on the validity of this
interpretation. Moreover, even under normal conditions,
NK cells are particularly sensitive to glucocorticoids [47]. It
is thus not unexpected that this cell type in particular would
respond by further increasing GR and thus GC sensitivity
under conditions of chronic inﬂammatory activation. This
may further indicate that the current protocol was not
long enough in duration to result in chronic downregulation
of GC sensitivity, i.e., the dams did not have a sustained
proinﬂammatory phenotype. However, given the continuum
of GR adaptation, if oﬀspring were to inherit a hyperre-
sponsiveness to glucocorticoids—as seen here in NK cells
and T-lymphocytes—they may be at risk of reaching the
threshold for glucocorticoid insensitivity relatively earlier
in life. This is in line with the earlier incidence of non-
communicable diseases in the modern era [48–50].
Monocyte and macrophage populations and their
response to LPS are well characterised. In the current study,
monocytes indeed exhibited an increased GR expression in
dams exposed to LPS, which is in line with the relevant liter-
atures [37, 51, 52] and an interpretation of a predominating
inﬂammatory proﬁle existing in the LPS-treated dams. In
contrast, macrophages had decreased GR expression levels
in response to LPS. Similar to current data, splenic macro-
phages previously displayed insensitivity to glucocorticoids
and enhanced IL-6 production in a model of chronic social
stress [53]. Although the corticosterone levels were not indic-
ative of glucocorticoid insensitivity in the current study, the
modulation of splenic cell composition and GR levels, which
was also reported in another model of chronic mild stress
[45], suggests a selective GR insensitivity in the splenic mac-
rophages, priming the immune system to a relatively more
proinﬂammatory phenotype.
Elucidation of splenic macrophage NLRP3 activation in
the chronic LPS MPSI model, through the expression of
pro-IL-1β and ASC, further supports this interpretation. In
the current study, when compared to saline-exposed con-
trols, chronic LPS administration resulted in higher unstimu-
lated pro-IL-1β production by F4/80+ CD11b+ splenic
macrophages of F0 dams. This ﬁnding corresponds to the
increased basal pro-IL-1β production-reported macrophages
of aged mice [54], as well as in chronic LPS exposure in rats,
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Figure 9: Relative expression levels of Pro-IL-1β and ASC formation in CD11b+F4/80+ splenic macrophages. Basal and LPS responses were
assessed in F0, F1, and F2 for both LPS and control groups. Two-way ANOVA and Fisher’s post hoc tests were used to compare LPS and
saline groups. Data is represented mean ± SEM, n = 8 per group. Signiﬁcance is depicted as follows: ∗∗∗p < 0 001 and ∗∗∗∗p < 0 001.
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where signiﬁcantly higher IL-1β secretion is reported at the
basal level [55]. Interestingly, when an acute added stressor
is applied, IL-1β secretion is unaltered from the basal level
[55], which is again in line with the current data. This sug-
gests that the NLRP3 complex formation has a rate-limiting
step in its response to chronic stress, possibly to prevent
continuous activation. This is supported by the literature,
which names caspase-1 as a rate-limiting enzyme in the
cleavage of pro-IL-1β to release IL-1β, in the context of
neuroinﬂammation [56].
More knowledge is undoubtedly required to fully eluci-
date all mechanisms and role players involved, particularly
within a human model. Nevertheless, gestational exposure
to chronic inﬂammation clearly results in signiﬁcant eﬀects
on the mother which is not readily resolved and may thus
be transferred to her progeny as a relatively proinﬂammatory
phenotype already at birth.
4.2. Transgenerational Inheritance of Chronic LPS
Administration in F1 and F2 Generations. There is a growing
body of evidence in support of generational transfer of
increased susceptibility to disease and dysregulation. For
example, in diabetes and obesity, there is a signiﬁcant associ-
ation between parental history of obesity and diabetes and
levels of serum fatty acid-binding protein 4, retinol-binding
protein 4, and adiponectin, favouring obesity the risk devel-
oping of these disorders in oﬀspring [57]. Furthermore, the
foetal-maternal uterine environment is reported to have
direct eﬀects on oﬀspring weight and metabolic outcomes
[58]. Diet-induced obesity has also been associated with
altered splenic CD4+ cells, macrophages, and dendritic cells
in mice [59] and elevated inﬂammatory cytokines and risk
of mortality [60]; with this, metabolic dysfunction is also seen
to be transferable to oﬀspring in murine studies [61]. In the
current study, both F1 and F2 generations of oﬀspring to
the LPS dams exhibited signiﬁcantly compromised physiol-
ogy. Our data is in line with the abovementioned ﬁndings
and also expands on the current knowledge, illustrating that
this inherited “proinﬂammatory proneness” may not be
limited to speciﬁc diseases but could be more generally
applicable to any parental chronic exposure involving
substantial inﬂammation.
In line with previous reports [15, 62], maternal LPS expo-
sure did not aﬀect oﬀspring basal corticosterone levels when
compared to controls. This is in support of our interpretation
of inherited inﬂammatory proneness, as F1LPS exhibited
HPA axis hyperactivation, while F2LPS displayed that an
HPA axis response may be attributed to relative adrenal
burnout [63]. This may also explain the rise in GR in the
majority of splenocytes assessed for F1. However, F2LPS
splenocytes maintained the increased GR levels when com-
pared to F2 control mice, perhaps as a countermeasure to
the relative adrenal hyporesponsiveness. Thus, in response
to chronic LPS exposure, maladaptation in oﬀspring may
be indicated by changes in HPA functionality rather than
GR levels speciﬁcally.
In our opinion, the GC and GR hyperresponse in
F1LPS splenocytes reported is due to an inﬂammatory
phenotype resulting from maternal inﬂammatory response
and subsequent placental inﬂammatory responses, which
was shown to induce indirect foetal damage, speciﬁcally
intestinal damage, which persists way beyond the postnatal
period [64].
In the current study, the placental inﬂammatory response
may explain the changes in leukocyte numbers in F1LPS.
While circulating leukocyte number and distribution
remained unaﬀected, a clear picture of an inherited altered
immune system is evident in splenocytes. In utero inﬂamma-
tory response to maternal LPS exposure was associated with
increased splenocyte counts, primarily due to a rise in lym-
phocyte populations. In contrast, neutrophil numbers were
relatively decreased—which we interpret as tissue sequestra-
tion of neutrophils participating in aﬀected areas of inﬂam-
mation. This is further supported by ﬂow cytometry results
indicating an increased conversion of splenic CD11b+
monocytes to CD11b+F4/80+ macrophages that primarily
produce IL-1β. Although the proinﬂammatory phenotype
observed in F1LPS had no increased capacity for NLRP3 acti-
vation or increased proinﬂammatory cytokine secretion
basally, during acute LPS challenge, both NLRP3 conversion
of pro-IL-1β to active IL-1β and proinﬂammatory cytokine
secretion were signiﬁcantly exacerbated in F1LPS in compar-
ison to controls. Chronic preconditioning with inﬂammatory
mediators, such as IL-1β, has been shown to induce immu-
notolerance, by downregulation of TLR4 and through stimu-
lation of corticosterone production [65], which may be the
case in F1LPS.
When considering F2LPS, a picture of relative immune
tolerance seems to emerge, suggesting that eﬀects of chroni-
cally elevated IL-1β on TLR4 in F1 may have been inherited
by F2LPS. For example, in contrast to the increase in splenic
WBCs in F1LPS, in F2LPS, splenic WBCs were decreased. Most
notably, macrophage frequency decreased in F2LPS. In addi-
tion, the available macrophages failed to activate NLRP3 in
response to stimulus, eﬀectively resulting in a much smaller
net IL-1β response upon acute in vitro challenge, in line with
TLR4 downregulation. This picture of relative immune toler-
ance was associated with an approximate (but statistically
insigniﬁcant) 20% decrease in GC levels.
Interestingly, the sustained upregulation of leukocyte GR
into the second generation of oﬀspring may suggest epige-
netic adaptation or primordial germline inheritance adapta-
tion. This is also in line with a previous report with
upregulated GR in response to chronic mild psychological
stress [45]. In the study by Nephew and colleagues, the hypo-
methylation of GR gene promotor regions was lost in the
second-generation oﬀspring. However, their model was
milder than the one employed in the current study [28]. A
review by Dunn, et al. [8] hypothesised that for a phenotype
to be inherited into one subsequent generation, in uteromod-
iﬁcation (epigenetic adaptation) is the only requirement.
However, for a phenotype to be inherited into two or more
subsequent generations, the stimulus has to be robust for
resulting adaptations to stably alter germ cells. Taken
together, the current study and that of Nephew et al. [28]
suggest that the plasticity of generational transfer may be
severity-dependent. Importantly, it also indicates that this
adaptation is not limited to infectious stimuli.
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The increased leukocyte GR expression showed increased
secretion of IFN-γ, TNF-α, IL-6, and IL-10 in F2LPS, a
response not signiﬁcantly present in F1LPS. Previously,
increased induced TNF-α [12] and IL-6 [66, 67] were also
reported in a model of chronic social stress, again suggesting
a stimulus-independent adaptive eﬀect. Furthermore, data
suggest independence of this adaptation from the NLRP3
inﬂammasome. Nevertheless, the increased levels of cyto-
kines other than IL-1β suggest an alternative source, possibly
lymphoid cells or neutrophils.
Though basal cytokine levels do not allude to a systemic
proinﬂammatory phenotype, which have been reported in
other stress models [12, 28, 68], there are two potential mech-
anisms that we propose to this outcome. Firstly, in F1LPS, the
upregulation of glucocorticoid sensitivity possibly reduced
cytolytic activity by reduction of histone promoter acetyla-
tion for perforin and granzyme B and TNF-α, IL-6, and
IFN-γ production, as previously reported for NK cells
[47, 69]. However, in F2LPS, where a picture of relative GC
hyposecretion seemed present, this downregulation may
have been abolished, resulting in increased cytokine release
from NK and potentially also other cells. Secondly, neutro-
phils speciﬁcally are negatively implicated in the primordial
generational programming in the F2 generation, as acute
high-dose LPS have been shown to increase neutrophil
counts as well as the GR receptor level on neutrophils [70]
and GR expression on macrophages [71]. Furthermore,
impaired translocation of activated GR was also demon-
strated in at least neutrophils and T-lymphocytes after LPS
exposure [70]. Thus, in a chronic stimulus setting, sustained
impaired GR function on speciﬁc leukocytes is probable and
in line with current results suggesting a relative proinﬂam-
matory outcome despite downregulated macrophage NLRP3
and increased GR expression levels. Future purpose designed
studies could shed further light on this probability.
When speciﬁcally considering the leukocyte GR data,
the response seen in the F0 model is mirrored in F1 and
F2, with exacerbation of the response with each successive
generation. This expands on the generally accepted report
ascribing reduced hippocampal GR promotor methylation
in oﬀspring from low grooming arch back nursing (LG-
ABN) mothers to diminished GR sensitivity, which per-
sisted to adulthood [5]. Our current data is also in line
with data from a transgenerational chronic social stress
(CSS) mouse model, where lower GR methylation was
reported in F1 CSS oﬀspring but not in F2 CSS [28]. This
may allude to epigenetic inheritance or primordial germ-
line inheritance, due to the chronic grandparent and in
utero parental exposure to LPS, with even higher respon-
siveness in the F2 generation despite the addition of an
unaﬀected parent.
5. Conclusion
In the current study, we show that in a mouse model of
chronic low-grade maternal inﬂammation induced by LPS
administration, long-standing reprogramming of the oﬀ-
spring phenotype may occur and this eﬀect was perpetu-
ated in the next generation without any further stimulus.
The maternal inﬂammatory state is mirrored and exacer-
bated in two subsequent generations of oﬀspring, suggest-
ing transgenerational inheritance of the inﬂammatory
phenotype and perhaps underlying epigenetic adaptation.
The current results also suggest that similar primordial
germline programming may occur in response to LPS
and/or psychological stressors. Thus, the current study con-
tributes to our understanding of parental contribution to
predisposition for the development of noncommunicable
chronic diseases.
Given these insights, it is imperative to conﬁrm and
further characterise the plasticity and mechanisms underly-
ing this “proinﬂammatory programming,” particularly in a
human model. Furthermore, potential sex-dependent diﬀer-
ences should be investigated.
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